Lessons learned from two decades of BRCA1 and BRCA2 genetic testing: the evolution of data sharing and variant classification.
作者信息
Toland Amanda E, Brody Lawrence C
机构信息
Departments of Cancer Biology and Genetics and Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
出版信息
Genet Med. 2019 Jul;21(7):1476-1480. doi: 10.1038/s41436-018-0370-4. Epub 2018 Nov 26.
Abstract
摘要
相似文献
1
Lessons learned from two decades of BRCA1 and BRCA2 genetic testing: the evolution of data sharing and variant classification.从BRCA1和BRCA2基因检测二十年中吸取的经验教训：数据共享与变异分类的演变
Genet Med. 2019 Jul;21(7):1476-1480. doi: 10.1038/s41436-018-0370-4. Epub 2018 Nov 26.
2
Variant classification changes over time in BRCA1 and BRCA2.BRCA1 和 BRCA2 中的变异分类随时间变化。
Genet Med. 2019 Oct;21(10):2248-2254. doi: 10.1038/s41436-019-0493-2. Epub 2019 Apr 11.
3
BRCA1/2 Variant Data-Sharing Practices.BRCA1/2 变异数据共享实践。
J Law Med Ethics. 2019 Mar;47(1):88-96. doi: 10.1177/1073110519840487.
4
Richard Graham Hay Cotton 1940-2015.理查德·格雷厄姆·海·科顿 1940 - 2015年。
Nat Genet. 2015 Aug;47(8):850. doi: 10.1038/ng.3369.
5
Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.临床变异分类：公共数据库与商业检测实验室的比较
Oncologist. 2017 Jul;22(7):797-803. doi: 10.1634/theoncologist.2016-0431. Epub 2017 Apr 13.
6
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.通过连锁研究对 101 个意义未明的 BRCA1 和 BRCA2 变异进行分类：一种强大的方法。
Am J Hum Genet. 2021 Oct 7;108(10):1907-1923. doi: 10.1016/j.ajhg.2021.09.003. Epub 2021 Sep 30.
7
Reclassification of and variants of uncertain significance: a multifactorial analysis of multicentre prospective cohort.多中心前瞻性队列的多因素分析：和意义不明变异体的重新分类。
J Med Genet. 2018 Dec;55(12):794-802. doi: 10.1136/jmedgenet-2018-105565. Epub 2018 Nov 10.
8
Data sharing: lessons from Copernicus and Kepler.数据共享：来自哥白尼和开普勒的经验教训。
BMJ. 2016 Sep 14;354:i4911. doi: 10.1136/bmj.i4911.
9
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel.基于证据的基因特异性 ACMG/AMP 变异分类推荐意见，来自 ClinGen ENIGMA BRCA1 和 BRCA2 变异 curation 专家小组。
Am J Hum Genet. 2024 Sep 5;111(9):2044-2058. doi: 10.1016/j.ajhg.2024.07.013. Epub 2024 Aug 13.
10
Gene patenting--is the pendulum swinging back?基因专利——钟摆正在摆回吗？
N Engl J Med. 2010 May 20;362(20):1855-8. doi: 10.1056/NEJMp1004026. Epub 2010 Apr 7.
引用本文的文献
1
Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing.聚（ADP - 核糖）聚合酶抑制剂的未开发潜力：从真实世界临床同源重组修复突变检测中汲取的经验教训。
World J Oncol. 2024 Aug;15(4):562-578. doi: 10.14740/wjon1820. Epub 2024 Jun 11.
2
Assessment of and Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry.基于真实世界数据登记研究中乳腺癌患者的 和 胚系变异数据评估。
JCO Clin Cancer Inform. 2024 May;8:e2300251. doi: 10.1200/CCI.23.00251.
3
Germline Missense Variants in : New Trends and Challenges for Clinical Annotation.中的种系错义变体：临床注释的新趋势与挑战
Cancers (Basel). 2019 Apr 12;11(4):522. doi: 10.3390/cancers11040522.
本文引用的文献
1
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.遗传性癌症基因检测后变异再分类的流行率。
JAMA. 2018 Sep 25;320(12):1266-1274. doi: 10.1001/jama.2018.13152.
2
Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry.前瞻性癌症遗传变异研究：基于祖源的重新分类率的变化。
J Natl Cancer Inst. 2018 Oct 1;110(10):1059-1066. doi: 10.1093/jnci/djy027.
3
Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.将 ACMG/AMP 变异分类指南建模为贝叶斯分类框架。
Genet Med. 2018 Sep;20(9):1054-1060. doi: 10.1038/gim.2017.210. Epub 2018 Jan 4.
4
Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014.2003-2014 年美国 18-64 岁女性中 BRCA 检测的利用和费用趋势。
Genet Med. 2018 Apr;20(4):428-434. doi: 10.1038/gim.2017.118. Epub 2017 Sep 21.
5
Consistency of and Variant Classifications Among Clinical Diagnostic Laboratories.临床诊断实验室之间以及变异分类的一致性。
JCO Precis Oncol. 2017 Jul;1. doi: 10.1200/PO.16.00020. Epub 2017 Apr 11.
6
FDA Approval of PARP Inhibitors and the Impact on Genetic Counseling and Genetic Testing Practices.美国食品药品监督管理局对聚（ADP-核糖）聚合酶抑制剂的批准及其对遗传咨询和基因检测实践的影响。
J Genet Couns. 2018 Feb;27(1):131-139. doi: 10.1007/s10897-017-0130-7. Epub 2017 Aug 5.
7
Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.将生殖系基因检测纳入早期乳腺癌治疗决策过程中的差距。
J Clin Oncol. 2017 Jul 10;35(20):2232-2239. doi: 10.1200/JCO.2016.71.6480. Epub 2017 Apr 12.
8
Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVar.临床实验室合作解决提交给 ClinVar 的变异解释差异。
Genet Med. 2017 Oct;19(10):1096-1104. doi: 10.1038/gim.2017.14. Epub 2017 Mar 16.
9
ClinVar: public archive of interpretations of clinically relevant variants.ClinVar：临床相关变异解读的公共存档库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8. doi: 10.1093/nar/gkv1222. Epub 2015 Nov 17.
10
Population genetic testing for cancer susceptibility: founder mutations to genomes.人群癌症易感性遗传检测：基因组中的起源突变。
Nat Rev Clin Oncol. 2016 Jan;13(1):41-54. doi: 10.1038/nrclinonc.2015.173. Epub 2015 Oct 20.
Zotero 插件